- $4.33bn
- $5.80bn
- $901.00m
- 65
- 89
- 76
- 90
R2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Realized & Unrealized Gains / Losses | |||||
Total Revenue | 2,190 | 1,197 | 538 | 421 | 901 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,268 | 1,088 | 117 | -329 | 278 |
Operating Profit | 922 | 109 | 421 | 750 | 623 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 877 | 1,496 | 487 | -883 | 955 |
Provision for Income Taxes | |||||
Net Income After Taxes | 865 | 1,473 | 460 | -871 | 1,205 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 938 | 1,755 | 538 | -870 | 1,118 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 902 | 1,719 | 502 | -906 | 1,082 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 41.1 | 77.9 | 21.6 | -52.7 | 68.5 |